Few hospital-acquired infections are as antibiotic-resistant as Pseudomonas aeruginosa. This opportunistic germ has earned a ...

Scientists are developing what they hope to be an alternative treatment for chronic urinary tract infections (UTI), which could help millions of patients suffering from the agonising condition.

Adding durvalumab to induction and maintenance with Bacillus Calmette–Guérin (BCG) can improve disease-free survival in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer, data ...

A Phase 3 study in the U.S. is planned to start in early 2026 to support a submission for FDA approval. MUNICH, Oct. 1, 2025 /CNW/ -- Vertanical today announced publication of results from two Phase 3 ...

VER-01 significantly reduced pain intensity in chronic low back pain compared with placebo, with effects sustained during 12 months of treatment. VER-01 was generally well tolerated, with no signs of ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Protein is having a moment in the health and wellness world. And for good reason: The macronutrient is ...

Rhapsido is the first FDA-approved BTKi for CSU, targeting patients unresponsive to H1 antihistamines. REMIX trials showed Rhapsido's superiority over placebo in reducing CSU symptoms by Week 12.

This story is sponsored by Sterling Orthopedic Pain & Spine. Many people lightheartedly joke about "having PTSD" (posttraumatic stress disorder) after unpleasant life experiences. But those who live ...

Protein is having a moment in the health and wellness world. And for good reason: The macronutrient is lauded for its role in muscle-building, losing weight, and maintaining a high metabolism, just to ...